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Bats are considered natural reservoirs of various, potentially zoonotic viruses, exemplified
by the influenza A-like viruses H17N10 and H18N11 in asymptomatic Neotropical bats.
These influenza viruses are evolutionarily distinct, are poorly adapted to laboratory
mice and ferrets and cannot reassort in vitro with conventional strains to form new
influenza subtypes. However, they have attracted renewed attention following reports
that their entry in host cells is mediated by the trans-species conserved MHC-II
proteins, suggesting that they hold zoonotic potential. Despite the recent studies, the
viruses’ epidemiology and public health significance remain incompletely understood.
Delineating the mechanistic basis of the interactions with their hosts and assessing their
global distribution are essential in order to fully assess the zoonotic threat that these
strains pose.
Keywords: bats, influenza virus, haemagglutinin, neuraminidase, Major Histocompatibility Complex (MHC) class
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INTRODUCTION
The Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS),
Nipah (NiV), Hendra (HeV), and Ebola (EBOV) viruses’ outbreaks confirmed the inextricable
nature of human and bat health and disease and highlighted that focusing on the “spillover”
potential of known, and novel, bat viruses is critical to predict and prevent pandemics. The
remarkable ability of bats to coexist with a wide range of viruses that would be pathogenic
in flightless mammals (Fl−M) is not yet fully understood but possibly relates to their unique,
flight-adapted antiviral immunity (Calisher et al., 2006; Hayman et al., 2013). Intriguingly, genetic
material from viruses that resemble influenza type A viruses has been recovered from asymptomatic
fruit bats of the Neotropic bat family Phyllostomidae (Sturnira lilium and Artibeus planirostris) in
several countries of Central and South America (Figure 1) (Tong et al., 2012, 2013; Campos et al.,
2019). Influenza A viruses (IAVs) are orthomyxoviruses with eight single-stranded negative-sense
viral RNAs (vRNAs) encapsidated into viral ribonucleoproteins (vRNPs). IAVs emerge from
aquatic birds, via genome reassortment and mutation, and are able to cause epidemics (and
sporadic pandemics; Simonsen, 1999) in humans, lower animals and birds (Simonsen, 1999). The
bat influenza viruses (BatIVs) are phylogenetically distinct from the conventional IAVs and they
were designated as H17N10 and H18N11 (Table 1). Bats in Latin America, but not in Central
Europe, have been found seropositive for BatIVs (Tong et al., 2013; Fereidouni et al., 2015).
Antibodies against human H2N2 and H3N2, as well as classical H9, have also been found in
bats elsewhere (L’vov et al., 1979; Kelkar et al., 1981; Isaeva et al., 1982), suggesting they are
susceptible to IAV infection. The epithelial kidney cells of flying foxes (Pteropus alecto) co-express
both avian (α2,3-Gal) and human (α2,6-Gal) sialic acid (SA) receptors (Chothe et al., 2017)
and are thus susceptible to infection by both avian and human IAVs, but more importantly
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FIGURE 1 | Countries of Central and South America where bat influenza A viruses have been reported. Map showing the global pattern of bat species richness was
provided by Clinton Jenkins (see BiodiversityMapping.org) using species data from The IUCN Red List of Threatened Species (2018; https://www.iucnredlist.org)
(Jenkins et al., 2013).
they allow reassortment between co-infecting influenza viruses
(Dlugolenski et al., 2013). The N-terminal domain of the
H17N10 PA subunit of the influenza virus polymerase complex
possesses endonuclease activity comparable to that of IAVs
(Tefsen et al., 2014). Equally intriguingly, in the position 627
of the polymerase gene PB2, one of the most commonly
identified IAV virulence markers, BatIVs have a serine compared
to glutamic acid in avian and lysine in mammalian influenza
strains, suggestive of an alternative evolutionary pathway for
avian IAV’s adaptation in mammals (Mehle, 2014). This all raised
the question whether novel IAVs could emerge from bats to
which human and animal populations would be immunologically
“naïve,” causing pandemics.
BatIVs ARE DISTINCT AND EMPLOY
UNCONVENTIONAL RECEPTORS FOR
CELL ENTRY
The genetic material of BatIVs is similar to classic flu viruses,
but their surface glycoproteins haemagglutinin (HA) and
neuraminidase (NA) are evolutionarily and functionally diverged
(Li et al., 2012; Zhu et al., 2012; Sun et al., 2013; Tong et al.,
2013). BatIVs cannot be cultured in embryonated chicken eggs
and do not agglutinate red blood cells (Tong et al., 2012, 2013).
Initial efforts by researchers to isolate live infectious BatIVs
directly from bats failed, due to unavailability of permissive
cell lines (Ciminski et al., 2017). In addition, research on these
viruses was further complicated by the dearth of bat cell lines
and the limited bat genomic data. Attempts to circumvent these
limitations have included: (i) using HA-17 or HA-18 pseudotyped
vesicular stomatitis virus (VSV) and HIV-1 based lentiviruses
(Hoffmann et al., 2016; Maruyama et al., 2016; Carnell et al.,
2018; Giotis et al., 2019), (ii) engineering BatIV/IAV chimaeric
viruses (Juozapaitis et al., 2014; Zhou et al., 2014), and (iii)
reconstructing authentic BatIVs using reverse genetics (Moreira
et al., 2016; Sato et al., 2019; Zhong et al., 2019). HA17-VSV was
able to infect bat cell lines (EidNi, HypNi, and EpoNi) but only a
few of the common Fl−M cell lines, including human U-87MG
glioblastoma and SK-Mel-28 melanoma cells, canine RIE 1495
and MDCK II kidney cells (Hoffmann et al., 2016; Maruyama
et al., 2016; Moreira et al., 2016). The identification of MDCK II,
in particular, as susceptible cell lines to BatIVs opened the way for
a more comprehensive characterization of these strains (Moreira
et al., 2016; Giotis et al., 2019; Karakus et al., 2019).
Crystal structure analyses revealed that the bat
haemagglutinins display typical HA protein folds but lack
any obvious cavity to accommodate SA, which are the
conventional receptors of IAVs. Recently, two independent
studies demonstrated that the cell-entry of H17N10 (Giotis
et al., 2019) and H18N11 (Karakus et al., 2019) is mediated
by MHC-II receptors that are well-conserved in many species.
Hence, immortalized cell lines that express MHC-II receptors on
their surface such as several human leukemia and lymphoma cell
lines Raji, Ramos, and BJAB B-lymphocytes could be used for the
study of the viruses’ biology (Giotis et al., 2019). Interestingly,
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TABLE 1 | List of distinctive features of IAVs and BatIVs.
IAVs BatIVs
Known hosts Birds, humans, swine, equine,
and marine mammals
New World bats
Clinical manifestation Mild to severe respiratory
disease to humans and birds,
cause outbreaks/epidemics, and
sporadically pandemics
Asymptomatic
(unclear)
Cell surface receptors/entry
factors
Sialic acids MHC-II
Role of haemagglutinin Cell attachment/entry Cell entry
Role of neuraminidase Sialidase activity Unknown
Culture in embryonated
chicken eggs
Yes (usually) No
Agglutination of red blood
cells
Yes (usually) No
Genetic drift Yes Yes
Genetic reassortment Yes Yes (not with IAVs)
Main transmission routes Respiratory droplets, direct
contact/fecal-oral
Fecal-oral (unclear)
ectopic expression of pig, mice, and chicken MHC-II have been
shown to confer susceptibility to H18N11 in non-susceptible
cells (Karakus et al., 2019) implying a potential role for the
respective animals as intermediary hosts. It is as yet unclear
whether MHC-II receptors function with other unknown factors
to facilitate virus internalization and also whether the viruses
remain cell associated following cell-entry and are being passed
on by direct cell-cell contact.
MHC-II molecules occur as three highly polymorphic
isotypes (HLA-DR, HLA-DP, and HLA-DQ). They are selectively
expressed on the surface of professional antigen presenting cells
(APCs), act as ligands for the T-cell receptor (TCR), and play
a key role in the presentation of foreign antigens to CD4+ T
helper cells and immune surveillance (Jones et al., 2006; Roche
and Furuta, 2015). Bats contain all classical MHC class II gene
families that are responsible for antigen presentation with an
extra DRB2 gene copy located outside the MHC-II region in P.
alecto (Ng et al., 2017). TheMHC-II dependent cell entry suggests
that BatIVs might hijack APCs such as B lymphocytes and
dendritic cells for viral dissemination and/or survival perhaps
in the early stages of infection. It is unknown to what degree
their binding to APCs might influence the global outcome of the
host immune responses. A blockade of TCR recognition by steric
hindrance as described for Epstein-Barr virus (Ressing et al.,
2003, 2005; Wiertz et al., 2007), could explain the asymptomatic
status of the infection in the captured NewWorld bats.
THE ENIGMATIC ROLE OF BAT
INFLUENZA VIRUSES’ NEURAMINIDASES
The bat neuraminidases (NAs) are structurally similar to classical
NAs but lack conserved amino acids for SA binding or cleavage
(Li et al., 2012; Zhu et al., 2012). Moreover, unlike classical
NAs, they display no enzymatic activity (Garcia-Sastre, 2012;
Carnell et al., 2018), have a dispensable role in viral entry
(Hoffmann et al., 2016; Maruyama et al., 2016; Giotis et al.,
2019) and their function is not yet elucidated. Recent studies
demonstrated that the passage of reverse-genetics-generated
H18N11 virus in cell cultures, accumulates mutations in the N11
protein that increase virus titers in culture and may enhance
organ tropism in vivo (Zhong et al., 2019). Ciminski et al.
demonstrated by utilizing a chimeric bat influenza virus (PR8-
H18N11) that viruses encoding the full-length N11 protein
exhibited a growth advantage over viruses that encode a
truncated protein version and also showed that N11 is essential
for viral transmission (Ciminski et al., 2019b). Another study
showed that the N10 protein facilitates heterosubtypic (H5 and
H7) influenza hemagglutinin-bearing pseudotype release in the
absence of another source of neuraminidase, indicating a possible
role of N10 in viral release (Carnell et al., 2018). It has been
proposed that N11 downregulates MHC-II, thereby facilitating
virion release but mechanistic data for such function is as yet
missing (Ciminski et al., 2019b). There is no evidence that a
functional balance exists between bat HAs and NAs although it
is possible that the proteins coordinate their actions. Despite the
recent progress in our understanding, the exact function of bat
NAs remains an enticing mystery.
INTRASPECIES AND INTERSPECIES
TRANSMISSION OF BAT INFLUENZA
VIRUSES
It is now becoming more evident that BatIVs may transmit in
a different manner than conventional flu strains. It has recently
been shown that the H18N11 virus readily transmits between
bats (Ciminski et al., 2019b). Following experimental intranasal
H18N11 infection, the Neotropical Phylostomidae bat species
Artibeus jamaicensis shed high viral loads via the fecal route and
were able to infect naïve contact animals (Ciminski et al., 2019b).
Histopathological analysis of the infected bats indicated that viral
replication proceeds in the follicle-associated epithelium of gut-
associated lymphoid tissue, suggesting virus uptake from the
gastrointestinal lumen (Ciminski et al., 2019b), in line with the
rich gut epithelial expression of MHC-II (Wosen et al., 2018).
Furthermore, the researchers detected high loads of H18N11
viral transcripts in rectal swabs and excretions (Ciminski et al.,
2019b). Collectively, these findings imply that an environmental
(fecal-oral) mode of BatIVs transmission is more likely than an
airborne one, albeit the latter is not yet compellingly disproved.
Other infection routes including subcutaneous, transplacental,
vaginal, intracranial infections have not yet been reported. In
contrast to bats, H18N11 has been reported to have limited
replicative ability in laboratory mice and more interestingly in
ferrets which share similar lung physiology and SA distributions
to humans (Ciminski et al., 2019b; Karakus et al., 2019; Zhong
et al., 2019). Whether these observations are animal/infection-
route-dependent or they actually reflect a low zoonotic risk for
BatIVs remains to be seen.
In absence of conclusive scientific proof, the question remains
as to whether BatIVs are confined to a sylvatic transmission cycle
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and perpetuate in Neotropical bat populations or are capable
of urban adaptation. Anthropogenic disruptions of ecological
habitats that led to urban transmission of other enzootic bat
viruses (i.e., HeV, NiV) have been extensively described in the
scientific literature. Despite the increasing disturbances in the
fire-prone Neotropical forests, New World bats have not yet
been implicated in the transmission of zoonotic viruses, other
than rabies, to humans (Moratelli and Calisher, 2015). Even so,
Latin America is home to the richest and most diverse bat fauna
in the world (Figure 1) including almost 150 Phyllostomidae
species (Jenkins et al., 2013) in which BatIVs have been detected.
Unlike African and Asian bats which are consumed regularly,
New World bats are only eaten by few native indigenous people
(Moratelli and Calisher, 2015). A possible exposure to infected
bat blood and body fluids may hypothetically create a pathway
for disease transmission to humans. Another scenario may
involve the accidental introduction of BatIVs to the local fauna
or other Phyllostomidae species such as the widespread blood-
eating vampire bat (Desmodus rotundus), which thrives in both
native and anthropogenically transformed ecosystems (Bergner
et al., 2020). Vampire bats have long been suspected of passing
on rabies to humans and livestock in Latin America by biting
and scratching (Rupprecht et al., 2002). It will be useful to
explore in future studies whether haematophagous bats can act
as maintenance hosts for BatIVs and if their biting can form a
potential zoonotic transmission route either directly or through
mammalian intermediate hosts.
THE HOST FACTORS REGULATING
BatIVs REPLICATION ARE
POORLY UNDERSTOOD
BatIVs, like all viruses, have to compromise with positive
and negative genetic factors present in target cells for their
survival at each replication stage. Little is known regarding
the interaction of BatIV proteins and RNA with the host or
viral factors even though such interactions may determine the
fate and/or efficiency of infection, transmission, and epidemic
potential of the viruses. Previous studies revealed that the
bat Nonstructural NS1 proteins can act as interferon (IFN)
antagonists in human cells, and likely inhibit induction of
IFN at a pretranscriptional level (Ciminski et al., 2017).
More recently, it has been shown that the IFN-induced
human MxA protein controls the replication of H18N11, but
it is not clear whether sufficient MxA-escape mutations in
H18N11 NP can be acquired in vivo that could potentially
result in full MxA resistance (Ciminski et al., 2019a). Nearly
all lab work examining host and viral immune-modulating
proteins is performed with human/rodent cell lines. The
difficulty in interpreting these data is that evolutionarily-
optimized immune factors behave differently in non-natural
hosts. Certainly, comprehensive kinetic analyses of immune-
responses to BatIVs using primary or immortalized bat cell lines
will be particularly informative. For instance, a comparison of
the transcriptome of BatIV infected versus uninfected bat cells
could help us identify specific immune genes contributing to
host resistance and the molecular mechanisms underlying the
viral pathogenesis.
DO BAT INFLUENZA VIRUSES POSE A
ZOONOTIC RISK?
Reassortment of gene segments between co-infecting viruses
is a key process mediating the genetic evolution of influenza
viruses and the generation of novel epidemic and pandemic
strains. BatIVs are able to reassort between themselves but
not with conventional IAVs in vitro (Juozapaitis et al., 2014;
Zhou et al., 2014). Generation of bat chimeric viruses was only
possible when the HA/NA coding regions were flanked with
the authentic BatIV packaging signals demonstrating packaging
incompatibilities between IAVs and BatIVs (Juozapaitis et al.,
2014; Zhou et al., 2014). This finding dismisses the scenario of
emergence of a new “reassortant” virus with human/avian IAVs
unless the bat viruses undergo major genetic changes over time.
However, the abilities of BatIVs to (i) reassort between
themselves, (ii) to mutate in order to infect and transmit
sustainably among their hosts, and (iii) enter human HLA-
DR+ cells, highlight that a zoonotic transmission of BatIVs is
theoretically possible. The documented spillover of other non-
reassortant bat-borne RNA viruses following continued host-
pathogen interaction (i.e., NiV and EBOV) lends certain credence
to this hypothesis, albeit clearly, supporting evidence is lacking.
To explore the ecological and evolutionary dynamics of these
and possibly other unknown influenza-A-like viruses, further
prevalence and serological studies in Neotropical bat populations
are required coupled with the surveillance of bat-exposed
humans and livestock. Surveys of bat colonies have previously
led to identification of other zoonotic viruses, including HeV in
Pteropus sp. in Australia, NiV in Pteropus lylei in Thailand, and
MARV in Rousettus aegyptiacus in Uganda (Wacharapluesadee
et al., 2010; Amman et al., 2012; Field et al., 2015). A
computational study which used spatial empirical models to
trace the steps of emergence of bat viruses and the transmission
opportunities to humans pinpointed sub-Saharan Africa as the
top-priority location for pathogen discovery in wildlife (Brierley
et al., 2016). West Subsaharan Africa, in particular, hosts
enormous populations of sedentary and migrating bats living
in proximity to human and animal populations. Considering
the number, the morbidity and mortality of emerging viruses
that are hosted in African bats as well as the serological
evidence against IAVs (Freidl et al., 2015), future surveillance and
serological studies could lead to the identification of novel bat
influenza subtypes.
CONCLUSIONS
In summary, BatIVs are unconventional influenza viruses that
resemble to some extent more paramyxoviruses rather than
typical orthomyxoviruses. Despite the recent findings on the
cell entry factors and NAs of these viruses, it is clear that
we only scratched the surface in terms of characterization
of these viruses. The scientific evidence so far indicate a
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limited spillover risk but data is not conclusive enough to
dismiss out of hand the possibility of zoonotic transmission.
Forecasting viral spillover is a challenging task and additional
interdisciplinary and more up-to-date approaches are warranted
to fully appreciate the ecology and the implications of these
viruses for public health. Future studies on BatIVs hold extra
value as they can provide broader mechanistic insights into
the molecular biology of influenza viruses and might inform
translational studies.
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